These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8276983)
1. The potential use of CO2-laser gingivectomy for phenytoin-induced gingival hyperplasia in mentally retarded patients. Roed-Petersen B J Clin Periodontol; 1993 Nov; 20(10):729-31. PubMed ID: 8276983 [TBL] [Abstract][Full Text] [Related]
2. The laser gingivectomy. The use of the CO2 laser for the removal of phenytoin hyperplasia. Pick RM; Pecaro BC; Silberman CJ J Periodontol; 1985 Aug; 56(8):492-6. PubMed ID: 3938990 [TBL] [Abstract][Full Text] [Related]
3. Use of CO2 laser for gingivectomy in a patient with Sturge-Weber disease complicated by dilantin hyperplasia. Hylton RP J Oral Maxillofac Surg; 1986 Aug; 44(8):646-8. PubMed ID: 2942651 [No Abstract] [Full Text] [Related]
4. Treatment of phenytoin-induced gingival hyperplasia by electrosurgery. Walker CR; Tomich CE; Hutton CE J Oral Surg; 1980 Apr; 38(4):306-11. PubMed ID: 6928462 [TBL] [Abstract][Full Text] [Related]
5. Removal of hyperplastic lesions of the oral cavity. A retrospective study of 128 cases. Tamarit-Borrás M; Delgado-Molina E; Berini-Aytés L; Gay-Escoda C Med Oral Patol Oral Cir Bucal; 2005; 10(2):151-62. PubMed ID: 15735548 [TBL] [Abstract][Full Text] [Related]
7. Comparison between traditional surgery, CO2 and Nd:Yag laser treatment for generalized gingival hyperplasia in Sturge-Weber syndrome: a retrospective study. Inchingolo F; Tatullo M; Abenavoli FM; Marrelli M; Inchingolo AD; Inchingolo AM; Dipalma G J Investig Clin Dent; 2010 Nov; 1(2):85-9. PubMed ID: 25427262 [TBL] [Abstract][Full Text] [Related]
8. Levels of 5,5-diphenylhydantoin and its major metabolite in human serum, saliva, and hyperplastic gingiva. Conard GJ; Jeffay H; Boshes L; Steinberg AD J Dent Res; 1974; 53(6):1323-9. PubMed ID: 4529919 [No Abstract] [Full Text] [Related]
9. Gingival hyperplasia associated with nifedipine therapy. Report of a case. Lederman D; Lumerman H; Reuben S; Freedman PD Oral Surg Oral Med Oral Pathol; 1984 Jun; 57(6):620-2. PubMed ID: 6588343 [TBL] [Abstract][Full Text] [Related]
10. [Clinical study of gingival hyperplasia in epilepsy patient]. Takagi M; Kojima T; Shimooka S; Katagiri M Shigaku; 1989 Dec; 77(4):1401-7. PubMed ID: 2535149 [TBL] [Abstract][Full Text] [Related]
11. [Case of gingival hyperplasia due to diphenylhydantoin]. Bella G; Rossetti B; Greco S; Indelicato F Minerva Stomatol; 1987 May; 36(5):367-71. PubMed ID: 3476825 [No Abstract] [Full Text] [Related]
12. Incidence and indications for surgical management of phenytoin-induced gingival overgrowth in a cerebral palsy population. Jones JE; Weddell JA; McKown CG J Oral Maxillofac Surg; 1988 May; 46(5):385-90. PubMed ID: 3163372 [TBL] [Abstract][Full Text] [Related]
18. Periodontic/orthodontic management of diphenylhydantoin gingival hyperplasia: case report. Vandersall DC; Slade D J Periodontol; 1976 Nov; 47(11):656-60. PubMed ID: 1068273 [TBL] [Abstract][Full Text] [Related]
19. [Prospects of surgical treatment in hydantoin-induced gingival hyperplasia]. Wörle M Dtsch Zahnarztl Z; 1976 Nov; 31(11):881-3. PubMed ID: 1068797 [TBL] [Abstract][Full Text] [Related]
20. The management of drug induced gingival hyperplasia in mentally retarded patients with hemophilia: a report of two cases. Murphy JB; Nersasian R; Clark A J Periodontol; 1978 Jan; 49(1):44-6. PubMed ID: 304480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]